Trade agreement reduces drug access in Guatemala

Growing use of intellectual property protection following the Central American Free Trade Agreement (CAFTA) is risking access to lower-cost drugs in Guatemala, claims a new study.

Growing use of intellectual property protection following the Central American Free Trade Agreement (CAFTA) is risking access to lower-cost drugs in Guatemala, claims a new study.

Meanwhile, some drugs that are no longer protected in the US are only now being IP protected in Guatemala, says...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Drug Pricing

More from Scrip